finanzen.net
24.04.2019 10:33
Bewerten
(0)

Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

DRUCKEN

UPPSALA, Sweden, April 24, 2019 /PRNewswire/ -- Researchers of the Erasmus University Medical Center in Rotterdam - the Netherlands, consider that the synthetic and fully resorbable TIGR® Matrix surgical mesh (Novus Scientific AB, Uppsala - Sweden) may reduce frequent risks related to the surgical repair of Sportsman's hernia.

Inguinal disruption - also commonly referred to as Sportman's hernia - is a group name for painful injuries in the groin area caused by repetitive strain and strenuous training. It occurs in up to 28% of high-performing athletes, and may occasionally affect non-athletes.[1,2]

Unlike true hernias, a Sportsman's hernia does not include the bulging of organs or fatty tissue through a hole in the weakened muscle or tendons of the abdomen.[1]

The initial treatment of Sportman's hernia includes physical therapy, rehabilitation programs, sometimes in combination with steroid injections.[1]

"A treatment option for patients not responding to initial therapy is placement of a permanent mesh by minimally invasive procedure," explained Prof. Johan Lange of the Department of Surgery at the Erasmus University MC. "Such mesh aims to support the damaged tendons and absorbs pressure during physical exercise."

Despite the promising results and often fast resumption of sport activities by the patient after the surgical repair, there have been several reports of chronic pain and other severe side effects related to permanent mesh placement.[3]

According to Prof. Gert-Jan Kleinrensink of the Department of Neuroscience at the Erasmus University MC, permanent, non-absorbable meshes can cause serious complications, including chronic post-operative pain. "We are very interested to evaluate whether a slowly resorbable surgical mesh, such as the TIGR® Matrix, could help prevent these issues."

The researchers of the R.E.P.A.I.R study group, who have published around 200 peer-reviewed articles on the use of surgical meshes in various procedures, are now planning a study to investigate the usefulness of the TIGR® Matrix surgical mesh for the treatment of inguinal disruption.

About the TIGR®Matrix

TIGR®Matrix is the first long-term resorbable, 100% synthetic, surgical mesh. Its unique technology consisting of dual-stage degradation and full resorption, paired with ease of use, is a significant step forward in surgical mesh technology.

The fast-degrading part improves the mesh' flexibility and stretchability, provides extra strength during the immediate healing phase, and gradually absorbs during the first four months. The slow-degrading part of the mesh provides optimal strength for up to nine months with complete resorption in approximately three years. TIGR®Matrix uses 100% synthetic polymers that are well documented, clinically proven, and commonly used in medical devices since the 1970s.

About Novus Scientific

Novus Scientific AB (www.novusscientific.com) develops, manufactures and markets resorbable implants that help the body's own healing. The headquarter, research and production facilities are located in Uppsala, Sweden.

Source
[1]   Sheen AJ, et al. Br J Sports Med. 2014;48(14):1079-87.
[2]   Nam A & Brody F. J Am Coll Surg. 2008;206(1):154-64.
[3]   Doctor HG. J Minim Access Surg. 2006;2(3):110-6.

Logo - https://mma.prnewswire.com/media/787447/Novus_Scientific_logo.jpg

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX schließt etwas fester -- Wall Street gibt ab -- Daimler bestätigt Prognose - Entscheidung über 'Projekt Zukunft' -- Commerzbank bestätigt Ziele 2019 -- Deutsche Bank, Wirecard, QUALCOMM im Fokus

Fed Minutes: Notenbanker sind trotz Bedenken mit abwartender Haltung zufrieden. US-Richter bestellt Mediator im Streit um glyphosathaltige Mittel von Bayer. BVB-Transferoffensive: Brandt, Schulz und Hazard perfekt. Chinas Präsident Xi: Internationale Lage "immer komplizierter". Diageo bekräftigt Prognose. Delivery Hero verkündet Platzierungspreis für Aktienoptionsprogramm. May verteidigt Brexit-Pläne.

Die 5 beliebtesten Top-Rankings

Diese Aktien hat Warren Buffett im Depot
Die Änderungen unter den Top-Positionen
Die erfolgreichsten Kinofilme der letzten 25 Jahre
Welche Titel knackten die Milliardenmarke an den Kinokassen?
In diesen Berufen bekommt man das höchste Gehalt
Mit welchem Beruf kommt man am ehesten an die Spitze?
Städte für Millionäre
Hier fühlen sich die Vermögenden am wohlsten
In diesen Ländern ist Netflix am billigsten
Wo zahlen Abonnenten am wenigsten?
mehr Top Rankings

Umfrage

Die rechtspopulistische FPÖ in Österreich hat für einen Skandal gesorgt. Wie glauben Sie wird sich das auf die Europawahlen auswirken?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Daimler AG710000
Deutsche Bank AG514000
TeslaA1CX3T
CommerzbankCBK100
NEL ASAA0B733
Amazon906866
Apple Inc.865985
BayerBAY001
Huawei TechnologiesHWEI11
BASFBASF11
Deutsche Telekom AG555750
Lufthansa AG823212
Infineon AG623100
Ballard Power Inc.A0RENB